EDITAS MEDICINE, INC. Restructuring and Related Cost, Accelerated Depreciation
EDITAS MEDICINE, INC. (EDIT) reported Restructuring and Related Cost, Accelerated Depreciation of $1.79 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveAcceleratedDepreciation · last filed 2026-08-05
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for the quarter ending 2025-12-31 was $0.00.
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for the quarter ending 2025-09-30 was $0.00.
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for the quarter ending 2025-06-30 was $1.80M.
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for the quarter ending 2025-03-31 was $700.00K.
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for fiscal 2025 was $1.79M.
- EDITAS MEDICINE, INC. restructuring and related cost, accelerated depreciation for fiscal 2024 was $0.00.
| Period end | Restructuring and Related Cost, Accelerated Depreciation 3 month | Restructuring and Related Cost, Accelerated Depreciation 3 month as first filed | Restructuring and Related Cost, Accelerated Depreciation 6 month | Restructuring and Related Cost, Accelerated Depreciation 9 month | Restructuring and Related Cost, Accelerated Depreciation 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $1.79M 10-K · filed 2026-03-09 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $1.80M derived: sum of 2 quarters · filed 2026-08-05 | $1.79M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $1.80M 10-Q · filed 2026-08-05 | $1.07M 10-Q · filed 2025-08-12 | $1.79M 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | $700.00K 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |